Azacitidine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Azacitidine and local guidelines before prescribing.
Hypomethylating agent
Mechanism
Hypomethylating nucleoside analogue.
Uses
Myelodysplastic syndromes, AML.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Myelosuppression, nausea, injection-site reactions, infection.
Interactions
Few.
Contraindications and cautions
Advanced liver tumour
Monitoring
FBC, LFT, renal function
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Caution in renal and hepatic impairment
Overdose and reversal
Supportive
Special advice
Subcutaneous cycles of 7 days; blood count before each cycle.
More from the textbook: uses, cautions and other points
- Azacitidine (hypomethylating) | Myelodysplasia, AML | Marrow suppression, injection site reactions
Haematology: Anatomy Physiology and Pharmacology - Azacitidine with venetoclax (lower-intensity treatment with good responses).
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - Chronic myelomonocytic leukaemia (CMML): Persistent monocytosis with dysplasia; MDS and MPN overlap; older people. Hydroxycarbamide, azacitidine, transplant.
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - Azacitidine (hypomethylating agent).
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - Azacitidine + venetoclax | AML in older or unfit patients; azacitidine alone in higher-risk MDS.
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - AML presents with marrow failure. Fit patients get intensive chemotherapy and transplant; unfit patients get azacitidine and venetoclax.
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - Epigenetic drugs - azacitidine and decitabine (hypomethylating agents - myelodysplasia, AML), HDAC inhibitors.
Cell Biology: Molecular biology, gene expression and laboratory techniques